News Focus
News Focus
Followers 55
Posts 4229
Boards Moderated 0
Alias Born 03/20/2014

Re: Investor2014 post# 379052

Thursday, 10/20/2022 8:17:35 AM

Thursday, October 20, 2022 8:17:35 AM

Post# of 517434
Come on, you made a prediction, don't go back on your word.

And in your defense, I can't believe I'm doing this.

Primary Outcome Measures :
ADAS-Cog (Alzheimer Disease Assessment Scale-Cognition) [ Time Frame: 48 weeks ]
Reduction in cognitive decline assessed from baseline over 48 weeks with ANAVEX2-73 compared to placebo using the Alzheimer Disease Assessment Scale-Cognition (ADAS-Cog)

ADCS-ADL (Activities of Daily Living) [ Time Frame: 48 weeks ]
Reduction in decline of the ability to perform daily activities assessed from baseline over 48 weeks with ANAVEX2-73 compared to placebo using the Activities of Daily Living Scale (ADCS-ADL

)
https://clinicaltrials.gov/ct2/show/NCT03790709?term=Anavex&draw=2&rank=6

All my posts are my opinion only and shouldn’t be used for decisions regarding purchasing or selling.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News